Digital
23rd - 24th March 2021

5th Annual MarketsandMarkets High Potent Medicines Virtual Conference (CET TIME ZONE)

One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations. 

Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. Globally, there is a significant growth in the incidence of cancer. Diseases like musculoskeletal diseases, glaucoma, and specifically cancer have a significant impact on the health status of people worldwide, with comparatively higher growth rates in developing countries.

 

The 5th Annual MarketsandMarkets High Potent Medicines Virtual Conference to be held on 23-24 March 2021. This conference would address the challenges in continual evolution of industry standards, technologies, and regulations. Leading experts from the industry will discuss the strategies for both in-house manufacturing and outsourcing by presenting expert keynote presentations, live case studies and breakthrough panel discussions.

WHAT TO EXPECT

Key Highlights

  • Process Development and scale up of HPAPI’s
  • Strategies for effective outsourcing partnership
  • Containment and Handling Strategies
  • Validation of cleaning procedures to avoid cross contamination
  • Regulatory Landscape
  • Hazard Assessment Classifications

Why Attend?

  • Utilizing the best practices to ensure safe and efficient production of high potent medicines
  • Training sessions on complex high potent compounds handling and containment issues
  • Understanding the updated regulatory guidelines in the HPAPI process
  • Implementing response plans to react to an unplanned event
  • Knowing the outsourcing strategies to effectively build a reliable supply chain

Who Should Attend?

From pharmaceutical and Biopharmaceutical manufacturing:

Chief executives, VP’s, Directors, Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, Toxicologists, Fellows, Investigators working in:

  • Research & Development
  • Manufacturing/Operations/Production
  • Maintenance
  • Engineering
  • Risk Assessments
  • Laboratory Services/Analytical
  • New Technologies
  • Process Development/Technical transfer

CONFERENCE AGENDA
CONFERENCE SPEAKERS
Advisors
Richard Denk
Richard Denk
Head Containment, SKAN AG, Switzerland
Brian Schmidt
Brian Schmidt
Global Head, Industrial Hygiene , Takeda, Switzerland
Speakers
Richard Denk
Richard Denk
Head Containment, SKAN AG, Switzerland
Brian Schmidt
Brian Schmidt
Global Head, Industrial Hygiene , Takeda, Switzerland
Fabio Zenobi
Fabio Zenobi
EHS Director, BSP Pharmaceuticals, Italy
Stefano Butti
Stefano Butti
Sales Director, Food Pharma Systems, Italy
Andreas Schreiner
Andreas Schreiner
Head of Validation, Novartis, Switzerland
Martin Axon
Martin Axon
Senior Principal Occupational Hygienist , SafeBridge Europe
Michel Crevoisier
Michel Crevoisier
Consultant, Ex-Novartis Consultant, Switzerland
Dean Calhoun
Dean Calhoun
President, CEO, Affygility Soultions, USA
SPONSORS
Silver
example-image

FPS

Speaking Partner
example-image

BSP Pharmaceuticals

example-image

Dec Group

PARTNERS
Media Partners
example-image

Pharma Journalist

example-image

PharmaTutor

example-image

PharmaVOICE

PAST EVENT GALLERY